Evaluation of Growth Hormone Deficiency with Low IGF-1 and Normal Other Pituitary Hormones
With low IGF-1 and all other pituitary hormones normal, you must perform GH provocative testing to confirm growth hormone deficiency—a low IGF-1 alone is insufficient for diagnosis in this scenario. 1
Diagnostic Algorithm
Step 1: Confirm the Low IGF-1 is Valid
Before proceeding with provocative testing, exclude conditions that can falsely lower IGF-1:
- Malnutrition or catabolic states
- Poorly controlled diabetes mellitus
- Liver disease
- Hypothyroidism (though you've stated other pituitary hormones are normal)
- Oral estrogen therapy (significantly suppresses IGF-1)
- Chronic kidney disease
Step 2: Understand Why Provocative Testing is Mandatory
The Endocrine Society guidelines are explicit: a normal IGF-1 does not exclude GHD, and conversely, a low IGF-1 alone does not confirm it 1. This is because:
- IGF-1 is influenced by multiple factors beyond GH status (BMI, nutrition, age, sex, other hormones)
- Sensitivity is poor in adults, particularly those over 40 years
- In your case with only isolated low IGF-1 and no other pituitary deficits, the pretest probability of true GHD is lower than in patients with multiple pituitary hormone deficiencies
The guidelines state that provocative testing is mandatory when IGF-1 is low but there are fewer than 3 other pituitary hormone deficiencies 1.
Step 3: Select the Appropriate Provocative Test
First-line test options (in order of preference):
Insulin Tolerance Test (ITT) - Gold standard
- GH peak <5.1 μg/L indicates GHD
- Contraindications: seizure disorder, ischemic heart disease, elderly patients
GHRH-Arginine Test - Excellent alternative (currently unavailable in many regions)
- GH peak <4.1 μg/L indicates GHD
- Caution: Can give false-normal results in hypothalamic GHD (e.g., post-radiation)
- BMI affects cut-points significantly
Glucagon Stimulation Test - Third choice when ITT contraindicated and GHRH unavailable
- Generally well-tolerated
- Specific cut-points vary by protocol
Step 4: Consider Need for Two Tests
For idiopathic isolated GHD in adults (your scenario), two abnormal provocative tests strengthen diagnostic certainty 1. This is particularly important because:
- Idiopathic isolated GHD occurring de novo in adults is not a well-recognized entity 4
- Single test false-positive rates exist
- Insurance requirements often mandate two tests
Step 5: Exceptions Where Provocative Testing May Be Optional
You would NOT need provocative testing if the patient had:
- ≥3 other pituitary hormone deficiencies plus low IGF-1 1
- Structural hypothalamic-pituitary lesion with multiple deficits
- History of craniopharyngioma or pituitary surgery
- High-dose cranial irradiation
- Proven genetic mutation affecting GH secretion
Since you've stated other pituitary hormones are normal, none of these exceptions apply.
Critical Pitfalls to Avoid
Do not diagnose GHD based solely on low IGF-1 in this clinical context. The evidence is unequivocal that this approach lacks specificity 1, 2, 5. Studies show that:
- Up to 20-30% of patients with documented GHD have normal IGF-1 levels
- Conversely, low IGF-1 can occur in many non-GHD conditions
- BMI significantly affects both IGF-1 levels and GH responses to testing
Age-specific considerations: If this is a young adult transitioning from pediatric care with childhood-onset GHD, higher cut-points may be needed (GH peak <6.1 μg/L for ITT, <19.0 μg/L for GHRH-arginine) 1.
Clinical Context Matters
While the low IGF-1 increases suspicion for GHD and supports proceeding with provocative testing, the clinical presentation should guide your decision to test 1, 3. Look for:
- Decreased lean body mass, increased visceral adiposity
- Reduced bone mineral density
- Impaired quality of life, fatigue, reduced exercise capacity
- Known risk factors: history of pituitary tumor, traumatic brain injury, subarachnoid hemorrhage
The low IGF-1 helps distinguish true GHD from obesity-related blunted GH responses, but definitive diagnosis requires provocative testing in your scenario 1.